What is the market cap of 3b Blackbio Dx Limited?

As of 02/04/2026, the market cap of 3b Blackbio Dx Limited stands at ₹1,054.80 Cr.

What is the PE and PB ratio of 3b Blackbio Dx Limited?

The PE and PB ratios of 3b Blackbio Dx Limited is 20.73 ratio and 346.17 ratio as of 02/04/2026.

What is the 52 week high and low of 3b Blackbio Dx Limited?

The 52 week high and low of 3b Blackbio Dx Limited is ₹2019.9 and ₹1151 as of 02/04/2026.

How can I buy 3b Blackbio Dx Limited share?

You can easily buy 3b Blackbio Dx Limited shares on the Bajaj Broking platform by opening a Demat account and verifying your KYC documents online. There are no account opening charges for a Demat account with Bajaj Broking.

What determines a company’s share price?

A company’s share price is determined by supply and demand dynamics in the stock market. Factors influencing it include the company’s financial performance, earnings growth, revenue, and profitability, as well as broader economic conditions, market sentiment, and investor perception. Other determinants include sector trends, government policies, interest rates, and global events. Positive news or growth prospects can drive demand and raise the share price, while negative developments can push it lower. Analysts’ recommendations, institutional buying or selling, and technical factors such as trading volume also influence price movements. Ultimately, the share price reflects the market’s collective view of a company’s current and future value.

What is the “last sale,” “bid,” and “ask” price of 3b Blackbio Dx Limited?

The “last sale” is the most recent price at which a stock, like 3b Blackbio Dx Limited , was traded. The “bid” price represents the highest price buyers are willing to pay, while the “ask” price is the lowest price sellers are ready to accept. The difference between the bid and ask is known as the spread. Monitoring these prices helps investors understand market sentiment and liquidity. For example, a narrow spread indicates high liquidity and active trading, while a wide spread may suggest lower activity or higher volatility. These metrics are crucial for executing timely buy or sell orders in the stock market.

How to read share price charts for 3b Blackbio Dx Limited?

Share price charts display the historical price movement of 3b Blackbio Dx Limited , helping investors analyse trends, patterns, and potential entry or exit points. Charts typically show candlestick patterns, line graphs, or bar charts, representing open, high, low, and close prices. Key indicators include moving averages, support and resistance levels, and trading volume. Candlestick patterns can reveal bullish or bearish trends, while volume confirms the strength of price movements. Investors can use charts for technical analysis to assess momentum, predict short-term fluctuations, or complement fundamental analysis for long-term decisions. Understanding trends over daily, weekly, or monthly periods helps in making informed trading and investment choices.

What is volatility, and how does it affect share price movement for 3b Blackbio Dx Limited?

Volatility measures the degree of price fluctuations of a stock over time. High volatility indicates that 3b Blackbio Dx Limited share price can experience large swings in short periods, while low volatility suggests stable prices. Factors causing volatility include market sentiment, earnings announcements, global events, economic indicators, and industry news. High volatility can create opportunities for traders to profit from rapid price changes but also increases risk for long-term investors. Understanding volatility helps investors manage risk, set stop-loss limits, and determine the appropriate investment horizon based on their risk tolerance.

3B BlackBio Dx Limited

3BBLACKBIO

Small Cap | Healthcare

₹1254

+99.59 (+8.62%)

‌

Stock price as on 02 Apr 2026 at 15:29 PM

3b blackbio dx limited share price update

As of the latest trading session, 3B Blackbio Dx Limited share price is currently at ₹1254, which is up by ₹99.59 from its previous closing. Today the...

3b Blackbio Dx Limited stock performance

Today’s low

₹1,110

Today’s high

₹1,254.05

₹1,254

52 week low

₹1,151

52 week high

₹2,019.9

₹1,254

Open

₹1,144.00

Previous close

₹1,154.40

Share volume

2,822

Total traded value (Lakh)

₹34.68

Upper circuit

₹1,385.25

Lower circuit

₹923.55

3b Blackbio Dx Limited fundamentals

Market cap (Cr)

₹1,054.80

P/E ratio (TTM)

20.73

Book value per share

₹346.17

Beta

0.93

Return on equity

19%

Earnings per share (TTM)

₹59.54

Dividend yield

0.32%

Net profit/quarter (Cr)

₹14.46

3b Blackbio Dx Limited financials

(Values in Cr)

Revenue

Net income

Particulars	Dec 25 (₹ value in crores)
Revenue	₹24.38
Operating expense	₹10.15
Net income	₹14.46
Net profit margin	59.31%
Earning per share	₹16.88
EBITDA	₹19.09
Effective tax rate	23.32%

Particulars	Sep 25 (₹ value in crores)
Revenue	₹27.91
Operating expense	₹12.29
Net income	₹14.94
Net profit margin	53.52%
Earning per share	₹17.44
EBITDA	₹19.75
Effective tax rate	23.46%

Particulars	Jun 25 (₹ value in crores)
Revenue	₹20.36
Operating expense	₹8.99
Net income	₹12.46
Net profit margin	61.19%
Earning per share	₹14.54
EBITDA	₹15.91
Effective tax rate	20.53%

Particulars	Mar 25 (₹ value in crores)
Revenue	₹23.02
Operating expense	₹13.78
Net income	₹9.24
Net profit margin	40.13%
Earning per share	₹10.79
EBITDA	₹14.37
Effective tax rate	34.65%

Particulars	Dec 24 (₹ value in crores)
Revenue	₹23.43
Operating expense	₹8.70
Net income	₹13.45
Net profit margin	57.4%
Earning per share	₹15.70
EBITDA	₹17.97
Effective tax rate	24.13%

Particulars	Mar 25 (₹ value in crores)
Revenue	₹90.53
Operating expense	₹41.63
Net income	₹47.56
Net profit margin	52.53%
Earning per share	₹55.51
EBITDA	₹64.89
Effective tax rate	25.6%

Particulars	Mar 24 (₹ value in crores)
Revenue	₹70.72
Operating expense	₹36.58
Net income	₹34.21
Net profit margin	48.37%
Earning per share	₹39.93
EBITDA	₹47.41
Effective tax rate	26.33%

Particulars	Mar 23 (₹ value in crores)
Revenue	₹59.34
Operating expense	₹30.75
Net income	₹26.42
Net profit margin	44.52%
Earning per share	₹35.27
EBITDA	₹36.84
Effective tax rate	26.28%

Particulars	Mar 22 (₹ value in crores)
Revenue	₹15.52
Operating expense	₹17.16
Net income	₹8.01
Net profit margin	51.61%
Earning per share	₹10.67
EBITDA	₹8.86
Effective tax rate	5.43%

Particulars	Mar 21 (₹ value in crores)
Revenue	₹14.36
Operating expense	₹16.00
Net income	₹1.72
Net profit margin	11.97%
Earning per share	₹2.29
EBITDA	₹2.51
Effective tax rate	17.78%

Particulars (annual)	Mar 25 (₹ value in crores)
Book value per share	₹313.27
Return on Equity (ROE)	19.41%
Return on Capital Employed (ROCE)	26.03%
Total debt to equity ratio	-
EBITDA margin	67.58%

Particulars (annual)	Mar 24 (₹ value in crores)
Book value per share	₹260.32
Return on Equity (ROE)	15.42%
Return on Capital Employed (ROCE)	21.2%
Total debt to equity ratio	0.01
EBITDA margin	61.4%

Particulars (annual)	Mar 23 (₹ value in crores)
Book value per share	₹225.60
Return on Equity (ROE)	14.98%
Return on Capital Employed (ROCE)	20.24%
Total debt to equity ratio	0.01
EBITDA margin	58.81%

Particulars (annual)	Mar 22 (₹ value in crores)
Book value per share	₹204.26
Return on Equity (ROE)	22.59%
Return on Capital Employed (ROCE)	29.92%
Total debt to equity ratio	0.02
EBITDA margin	54.57%

Particulars (annual)	Mar 21 (₹ value in crores)
Book value per share	₹176.27
Return on Equity (ROE)	138.73%
Return on Capital Employed (ROCE)	179.45%
Total debt to equity ratio	0.03
EBITDA margin	67.43%

Particulars (annual)	Mar 25 (₹ value in crores)
Book value per share	₹318.36
Return on Equity (ROE)	19%
Return on Capital Employed (ROCE)	25.53%
Total debt to equity ratio	-
EBITDA margin	71.68%

Particulars (annual)	Mar 24 (₹ value in crores)
Book value per share	₹265.84
Return on Equity (ROE)	16.14%
Return on Capital Employed (ROCE)	21.82%
Total debt to equity ratio	0.01
EBITDA margin	67.05%

Particulars (annual)	Mar 23 (₹ value in crores)
Book value per share	₹228.91
Return on Equity (ROE)	24.01%
Return on Capital Employed (ROCE)	32.09%
Total debt to equity ratio	0.02
EBITDA margin	62.08%

Particulars (annual)	Mar 22 (₹ value in crores)
Book value per share	₹31.94
Return on Equity (ROE)	34.39%
Return on Capital Employed (ROCE)	33.57%
Total debt to equity ratio	0.1
EBITDA margin	57.09%

Particulars (annual)	Mar 21 (₹ value in crores)
Book value per share	₹30.24
Return on Equity (ROE)	7.92%
Return on Capital Employed (ROCE)	9.48%
Total debt to equity ratio	0.13
EBITDA margin	17.48%

Particulars	Mar 25 (₹ value in crores)
Cash and short term investments	₹68.83
Total assets	₹295.71
Total liabilities	₹295.71
Total equity	₹271.00
Shares outstanding	₹0.85
Price to book ratio	₹5.08
Return on assets (%)	16.12%
Return on capital	17.58%

Particulars	Mar 24 (₹ value in crores)
Cash and short term investments	₹62.14
Total assets	₹248.10
Total liabilities	₹248.10
Total equity	₹225.47
Shares outstanding	₹0.85
Price to book ratio	₹2.89
Return on assets (%)	12.93%
Return on capital	14.18%

Particulars	Mar 23 (₹ value in crores)
Cash and short term investments	₹59.20
Total assets	₹214.05
Total liabilities	₹214.05
Total equity	₹195.91
Shares outstanding	₹0.85
Price to book ratio	₹1.82
Return on assets (%)	12.11%
Return on capital	13.1%

Particulars	Mar 22 (₹ value in crores)
Cash and short term investments	₹28.89
Total assets	₹192.09
Total liabilities	₹192.09
Total equity	₹172.07
Shares outstanding	₹0.75
Price to book ratio	₹10.68
Return on assets (%)	16.76%
Return on capital	18.44%

Particulars	Mar 21 (₹ value in crores)
Cash and short term investments	₹35.07
Total assets	₹193.52
Total liabilities	₹193.52
Total equity	₹148.27
Shares outstanding	₹0.75
Price to book ratio	₹9.41
Return on assets (%)	58.83%
Return on capital	75.77%

Particulars	Mar 25 (₹ value in crores)
Cash and short term investments	₹62.63
Total assets	₹297.12
Total liabilities	₹297.12
Total equity	₹272.78
Shares outstanding	₹0.85
Price to book ratio	₹5.08
Return on assets (%)	16%
Return on capital	17.42%

Particulars	Mar 24 (₹ value in crores)
Cash and short term investments	₹54.87
Total assets	₹249.82
Total liabilities	₹249.82
Total equity	₹227.78
Shares outstanding	₹0.85
Price to book ratio	₹2.89
Return on assets (%)	13.69%
Return on capital	14.97%

Particulars	Mar 23 (₹ value in crores)
Cash and short term investments	₹50.35
Total assets	₹213.66
Total liabilities	₹213.66
Total equity	₹196.09
Shares outstanding	₹0.85
Price to book ratio	₹1.82
Return on assets (%)	12.36%
Return on capital	13.34%

Particulars	Mar 22 (₹ value in crores)
Cash and short term investments	₹1.85
Total assets	₹31.60
Total liabilities	₹31.60
Total equity	₹23.92
Shares outstanding	₹0.75
Price to book ratio	₹10.68
Return on assets (%)	25.33%
Return on capital	30.26%

Particulars	Mar 21 (₹ value in crores)
Cash and short term investments	₹1.70
Total assets	₹28.88
Total liabilities	₹28.88
Total equity	₹22.65
Shares outstanding	₹0.75
Price to book ratio	₹9.41
Return on assets (%)	5.94%
Return on capital	6.97%

Particulars	Mar 25 (₹ value in crores)
Net income	₹63.99
Cash from operations	₹58.14
Cash from investing	-₹33.84
Cash from financing	-₹3.21
Net change in cash	₹6.29
Free cash flow	₹59.04

Particulars	Mar 24 (₹ value in crores)
Net income	₹44.33
Cash from operations	₹37.79
Cash from investing	-₹20.31
Cash from financing	-₹3.62
Net change in cash	₹3.00
Free cash flow	₹38.29

Particulars	Mar 23 (₹ value in crores)
Net income	₹35.30
Cash from operations	₹29.22
Cash from investing	₹14.73
Cash from financing	-₹5.00
Net change in cash	₹30.01
Free cash flow	₹31.25

Particulars	Mar 22 (₹ value in crores)
Net income	₹43.22
Cash from operations	₹47.88
Cash from investing	-₹28.44
Cash from financing	-₹15.07
Net change in cash	-₹6.18
Free cash flow	₹50.15

Particulars	Mar 21 (₹ value in crores)
Net income	₹152.03
Cash from operations	₹135.40
Cash from investing	-₹70.25
Cash from financing	-₹1.56
Net change in cash	₹25.69
Free cash flow	₹137.08

Particulars	Mar 25 (₹ value in crores)
Net income	₹63.92
Cash from operations	₹59.31
Cash from investing	-₹33.63
Cash from financing	-₹3.07
Net change in cash	₹7.75
Free cash flow	₹60.00

Particulars	Mar 24 (₹ value in crores)
Net income	₹46.44
Cash from operations	₹39.30
Cash from investing	-₹20.31
Cash from financing	-₹3.61
Net change in cash	₹4.52
Free cash flow	₹39.81

Particulars	Mar 23 (₹ value in crores)
Net income	₹35.84
Cash from operations	₹30.14
Cash from investing	-₹7.80
Cash from financing	-₹2.89
Net change in cash	₹10.46
Free cash flow	₹31.10

Particulars	Mar 22 (₹ value in crores)
Net income	₹8.46
Cash from operations	₹8.14
Cash from investing	-₹1.52
Cash from financing	-₹6.30
Net change in cash	₹0.14
Free cash flow	₹9.66

Particulars	Mar 21 (₹ value in crores)
Net income	₹2.08
Cash from operations	₹3.18
Cash from investing	-₹0.17
Cash from financing	-₹1.59
Net change in cash	₹1.02
Free cash flow	₹3.33

Company name	Price	P/E	P/B	Market cap	52 week low/high
APOLLO HOSPITALS ENTERPRISE LT	₹7,549.90	59.76	11.94	₹1,08,555.98	₹6,017.95 / ₹8,099.00
FORTIS MALAR HOSPITALS LIMITED	₹50.79	20.99	2.77	₹95.19	₹46.65 / ₹98.70
SHREE PACETRONIX LTD.	₹115.00	16.99	2.58	₹42.26	₹61.11 / ₹283.15
TRANSGENE BIOTEK LTD.	₹2.50	0	2.05	₹18.94	₹1.83 / ₹5.26

Company name	Price	P/E	P/B	Market cap	52 week low/high
APOLLO HOSPITALS ENTERPRISE LT	₹7,549.90	59.76	11.94	₹1,08,555.98	₹6,017.95 / ₹8,099.00
FORTIS MALAR HOSPITALS LIMITED	₹50.79	20.99	2.77	₹95.19	₹46.65 / ₹98.70
SHREE PACETRONIX LTD.	₹115.00	16.99	2.58	₹42.26	₹61.11 / ₹283.15
TRANSGENE BIOTEK LTD.	₹2.50	0	2.05	₹18.94	₹1.83 / ₹5.26

3b Blackbio Dx Limited technical summary

₹1229

-0.41 ▼

Bearish

Bullish

5 Day1,231.9

10 Day1,273.1

12 Day1,291.9

20 Day1,355.7

26 Day1,387.2

50 Day1,436.4

100 Day1,452

200 Day1,465.1

Investment Returns

Over 1 Month22.19%▼

Over 3 Months13.33%▼

Over 6 Months10.75%▼

Over 1 Year31.28%▼

3b Blackbio Dx Limited Shareholding pattern

Public

54.27%

Promoter holdings

41.27%

FII

2.56%

DII

1.87%

Promoter shares

Promoter shares	Share	Category
Mithla Dubey	10,59,770 (12.35%)	Shareholding of Promoter and Promoter Group
Mithala Laboratories Private Limited	8,20,700 (9.56%)	Shareholding of Promoter and Promoter Group
Dhirendra Dubey	7,24,098 (8.44%)	Shareholding of Promoter and Promoter Group
Rashi Daga	4,55,070 (5.3%)	Public Shareholding
Prateek Goel	4,41,435 (5.14%)	Public Shareholding

About 3B BlackBio Dx Limited

3D Blackbio DX Limited, formerly known as Kilpest India Limited was incorporated on May 25, 1972 as one of India's leading agro-business companies. Thereafter, the holding Company, Kilpest India Limited got merged with 3B BlackBio Biotech India Limited and as per the Scheme of Amalgamation, the name of the Company was changed from Kilpest India Limited to 3B BlackBio DX Limited in August, 2023. The Company is a leading Indian biotech firm focused on molecular diagnostics (PCR kits, enzymes, reagents for diseases like cancer/ infectious diseases) under the 'TRUPCR' brand, alongside developing Next-Gen Sequencing (NGS) assays (TRUNGS) & Rapid Tests (TRURAPID), while continuing its traditional agrochemicals business (pesticides, bio-products), serving both labs and government sectors, driven by R&D for innovative solutions. The Company has representation in India in the field of agriculture business comprising crop protection, public health products and bio-products and is reputed reliable supplier to various Govt. organizations, such as Directorate General of Supplies & Transport, New Delhi, NAVY, Vishakapatnam/Mumbai, Food Corporation of India Raipur/ Bhopal/ Lucknow/ Mumbai/ Jaipur, NTPC, Bilaspur, Directorate of Health Service, M.P/Maharashtra/AP, Directorate of General Of Health Organization, Gujarat/U.P, Directorate General of Health services, MOH&FW (NVBDCP), Govt. of India, M/s Hindustan Latex Ltd, Noida, Director of Agriculture and Horticulture, M.P./Trivandrum, Central/Western Railway, Mumbai, Northern Railway, New Delhi etc. the company has nationwide distribution network of over 2000 dealers. It possess well equipped R&D laboratory duly approved and recognized by DSIR, Ministry of Science and Technology, Government of India. Advanced instrumentation facility supported by equally competent team of scientists and technicians lay down a strong R&D foundation. Clean and hygienic environment ensure the consistency and reliability of results. Laboratory studies are planned, performed, monitored, recorded, applied in small scale field and then tabulated. The products are manufactured to high International specifications with stringent quality control from raw material procurement to finished goods dispatch. The company's manufacturing process is complimented with the technical expertise and it has attained high standard suited to customer needs on 23-7-2002. Kilpest has received accreditation of International standard ISO 9001-2000 certified company. The companyhas diversified manufacturing in the field of micronutrients, bioproducts and plant growth regulators etc. The company is also exporting its products to Bangladesh and Afghanistan. In 2011-12, the Company launched Novel Biotech Indo-Spanish Joint Venture Project in Govindpura, Bhopal, Madhya Pradesh. It ventured into Diagnostic Service. In June, 2020, the Company launched , its single tube multiplex assay for TRUPCR SARS-CoV-2 RTqPCR Kit (Real-Time PCR based detection of SARS-CoV-2 virus) Version 3.2. With this, 3B BlackBio Biotech India Ltd. became first ever Indian molecular diagnostics company to receive US FDA-(EUA). Company launched NGS based 'TRUNGSr Solid Tumor Panel' for detection of SNVs, Indels, CNVs and RNA fusions in 35 marker genes and hotspots in 6 pharmocogenomics genes associated with solid tumors such as lung, gastro-intestinal/colorectal, breast, liver and ovarian tumors in FY 2024. The Rapid Kit manufacturing facility is made operational in 2025. The Company has added some novel products in Rapid Kit vertical for detection of Antimicrobial Resistance (AMR) genes. The Company has acquired Coris BioConcept SRL, Belgium in FY25.

Parent Organisation

Indian Private

NSE Symbol

3B BlackBio Dx Limited

Founded

1972

3B BlackBio Dx Limited CORPORATE ACTION

Dividend date	Dividend amount	Dividend type	Record date	Instrument type
19 Sept 2025	4	Final	19 Sept 2025	Equity shares
17 Sept 2024	3	Final	18 Sept 2024	Equity shares
15 Sept 2023	2.5	Final	15 Sept 2023	Equity shares
14 Sept 2022	2.5	Final	16 Sept 2022	Equity shares
14 Sept 2021	8	Special	16 Sept 2021	Equity shares
14 Sept 2021	1	Final	16 Sept 2021	Equity shares
19 Mar 2020	0.7	Interim	20 Mar 2020	Equity shares
17 Sept 2019	0.5	Final	19 Sept 2019	Equity shares
17 Sept 2018	0.5	Final	19 Sept 2018	Equity shares
15 Sept 2017	0.3	Final	19 Sept 2017	Equity shares
19 Sept 2011	1	Final	21 Sept 2011	Equity shares
18 Sept 2007	1	Final	20 Sept 2007	Equity shares

View more stocks

apollo hospitals enter. l

₹7,303.3

▼ 0.02%

max healthcare institute limit

₹946

▼ 1.26%

fortis healthcare ltd

₹793.05

▼ 0.18%

aster dm healthcare limited

₹658.9

▼ 4.22%

narayana hrudayalaya ltd.

₹1,630

▼ 0.35%

global health limited

₹1,001.3

▲ 1.13%

krishna inst of med sci l

₹625.4

▲ 0.12%

What’s trending

All stocks

FRONTFN

FRONTLINE FINANCIAL SERVICES L

MOIL LIMITED

MANAS POLYMER N ENERGIE L

50.4

+8.4 (+20%)

GOKULAGRO

GOKUL AGRO RESOURCES LTD

191

+31.83 (+20%)

View all

Top gainers

HCL TECHNOLOGIES LTD

TECH MAHINDRA LIMITED

INFOSYS LIMITED

WIPRO LTD

Top losers

EICHER MOTORS LTD

ASIAN PAINTS LIMITED

ETERNAL LIMITED

SUN PHARMACEUTICAL IND L

1693.6

-34.90 (-2.02%)

View all

Frequently asked questions

 As of 02/04/2026, at 15:29 PM, the 3b Blackbio Dx Limited share price stands at ₹1254.

Related tags

Disclaimer

*Disclaimer for Bajaj Finance Limited (‘BFL’):

Stock trading business is carried by Bajaj Financial Securities Limited ("BFSL"), a broker and Depository Participant registered with Securities Exchange Board of India and offers various products/services related to Securities market (Securities market products/services). BFL merely facilitates display of data shared by BFSL on its webpage/mobile application. Such data received from BFSL, or any of its service providers is on “as is” basis. BFL does not make any representation or warranty, express or implied, regarding accuracy, completeness of such data displayed herein.

When you opt to avail the Securities market products/services of BFSL by clicking on the BFSL weblink/mobile app, you will be redirected to BFSL's web page/mobile app for initiation and completion of the transaction. You are supposed to exercise independent diligence by reading all the related documents carefully before deciding to invest in Securities market Products/services.

BFL is a Non-Banking Financial Company carrying the business of acceptance of deposits and providing lending solutions to Retail and Corporate customers. BFL does not offer nor advice on Securities market products/services and shall not be liable or responsible for any of your investment decision."

**Disclaimer: For Bajaj Financial Securities Limited

Investments in the securities market are subject to market risk, read all related documents carefully before investing.

Broking services offered by Bajaj Financial Securities Limited (Bajaj Broking). Reg Office: Bajaj Auto Limited Complex, Mumbai –Pune Road Akurdi Pune 411035. Corporate Office: Bajaj Financial Securities Limited, 1st Floor, Mantri IT Park, Tower B, Unit No 9 & 10, Viman Nagar, Pune, Maharashtra 411014. SEBI Registration No.: INZ000218931 | BSE Cash/F&O/CDS (Member ID:6706) | NSE Cash/F&O/CDS (Member ID: 90177) | DP registration No: IN-DP-418-2019 | CDSL DP No.: 12088600 | NSDL DP No. IN304300 | AMFI Registration No.: ARN –163403.

Details of Compliance Officer: Mr. Boudhayan Ghosh (For Broking/DP/Research) | Email: compliance_sec@bajajbroking.in | Contact No.: 020-4857 4486. For any investor grievances write to compliance_sec@bajajbroking.in/ compliance_dp@bajajbroking.in (DP related)

This content is for educational purpose only. Securities quoted are exemplary and not recommendatory.

Research Services are offered by Bajaj Broking as Research Analyst under SEBI Regn: INH000010043.

For more disclaimer, check here: https://www.bajajbroking.in/disclaimer

3B BlackBio Dx Limited

3b blackbio dx limited share price update

3b Blackbio Dx Limited stock performance

₹1,110

₹1,254.05

₹1,151

₹2,019.9

3b Blackbio Dx Limited fundamentals

3b Blackbio Dx Limited financials

Particulars

Dec 25 (₹ value in crores)

Revenue

₹24.38

Operating expense

₹10.15

Net income

₹14.46

Net profit margin

59.31%

Earning per share

₹16.88

EBITDA

₹19.09

Effective tax rate

23.32%

Particulars

Sep 25 (₹ value in crores)

Revenue

₹27.91

Operating expense

₹12.29

Net income

₹14.94

Net profit margin

53.52%

Earning per share

₹17.44

EBITDA

₹19.75

Effective tax rate

23.46%

Particulars

Jun 25 (₹ value in crores)

Revenue

₹20.36

Operating expense

₹8.99

Net income

₹12.46

Net profit margin

61.19%

Earning per share

₹14.54

EBITDA

₹15.91

Effective tax rate

20.53%

Particulars

Mar 25 (₹ value in crores)

Revenue

₹23.02

Operating expense

₹13.78

Net income

₹9.24

Net profit margin

40.13%

Earning per share

₹10.79

EBITDA

₹14.37

Effective tax rate

34.65%

Particulars

Dec 24 (₹ value in crores)

Revenue

₹23.43

Operating expense

₹8.70

Net income